Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 13 | $984,024 |
Sells | 7 | $258,942 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 Jun 2024 16:38 | CLSD | Clearside Biomedical Inc | CHONG NGAI HANG VICTOR | Chief Medical Officer | 24 Jun 2024 | Purchase | 23,500 | 1.06 | 24,910 | D |
15 May 2024 17:28 | CLSD | Clearside Biomedical Inc | YERXA BENJAMIN R | Director | 15 May 2024 | Purchase | 7,813 | 1.31 | 10,235 | D |
19 Apr 2024 09:45 | CLSD | Clearside Biomedical Inc | GIBNEY ANTHONY S | Director | 18 Apr 2024 | Purchase | 93,290 | 1.3 | 121,277 | D |
19 Apr 2024 09:45 | CLSD | Clearside Biomedical Inc | GIBNEY ANTHONY S | Director | 17 Apr 2024 | Purchase | 6,710 | 1.25 | 8,388 | D |
20 Mar 2024 16:30 | CLSD | Clearside Biomedical Inc | CHONG NGAI HANG VICTOR | CHIEF MEDICAL OFFICER | 20 Mar 2024 | Purchase | 30,000 | 1.6 | 48,000 | D |
09 Feb 2024 13:00 | CLSD | Clearside Biomedical Inc | WHITMORE BRADFORD T | 10% | 07 Feb 2024 | Purchase | 444,444 | 1.35 | 599,999 | D |
19 Jan 2024 18:26 | CLSD | Clearside Biomedical Inc | LASEZKAY GEORGE M | CEO | 19 Jan 2024 | Sale | 18,000 | 1.27 | 22,860 | D |
19 Jan 2024 18:25 | CLSD | Clearside Biomedical Inc | DEIGNAN CHARLES A. | Chief Financial Officer | 19 Jan 2024 | Sale | 12,900 | 1.28 | 16,512 | D |
01 Nov 2023 16:24 | CLSD | Clearside Biomedical Inc | WHITMORE BRADFORD T | 10% | 01 Nov 2023 | Purchase | 64,366 | 0.7442 | 47,901 | D |
01 Nov 2023 16:24 | CLSD | Clearside Biomedical Inc | WHITMORE BRADFORD T | 10% | 30 Oct 2023 | Purchase | 600 | 0.685 | 411 | D |
01 Nov 2023 16:24 | CLSD | Clearside Biomedical Inc | WHITMORE BRADFORD T | 10% | 31 Oct 2023 | Purchase | 70,812 | 0.7278 | 51,537 | D |
04 Oct 2023 17:06 | CLSD | Clearside Biomedical Inc | HUTSON NANCY J | Director | 03 Oct 2023 | Purchase | 10,000 | 0.86 | 8,600 | D |
25 Sep 2023 16:34 | CLSD | Clearside Biomedical Inc | THORP CLAY | Director | 25 Sep 2023 | Purchase | 10,000 | 0.86 | 8,600 | D |
20 Jan 2023 16:32 | CLSD | Clearside Biomedical Inc | CIULLA THOMAS | Chief Medical Officer | 20 Jan 2023 | Sale | 13,700 | 1.47 | 20,139 | D |
20 Jan 2023 16:31 | CLSD | Clearside Biomedical Inc | LASEZKAY GEORGE M | CEO | 19 Jan 2023 | Sale | 20,030 | 1.46 | 29,244 | D |
20 Jan 2023 16:29 | CLSD | Clearside Biomedical Inc | DEIGNAN CHARLES A. | Chief Financial Officer | 19 Jan 2023 | Sale | 14,030 | 1.5 | 21,045 | D |
11 Jan 2023 16:39 | CLSD | Clearside Biomedical Inc | CIULLA THOMAS | Chief Medical Officer | 10 Jan 2023 | Sale | 2,170 | 1.62 | 3,515 | D |
21 Dec 2022 16:26 | CLSD | Clearside Biomedical Inc | THORP CLAY | Director | 21 Dec 2022 | Purchase | 14,000 | 1.019 | 14,266 | D |
19 Dec 2022 19:40 | CLSD | Clearside Biomedical Inc | THORP CLAY | Director | 10 Feb 2021 | Sale A | 32,873 | 4.43 | 145,627 | D |
21 Nov 2022 08:12 | CLSD | Clearside Biomedical Inc | HUTSON NANCY J | Director | 17 Nov 2022 | Purchase | 30,000 | 1.33 | 39,900 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)